The European Medicines Agency has published on its website a concise report of a survey targeted to academic stakeholders in the context of the definition of a framework of collaboration with academia. It concludes that, in view of the growing complexity with which new medicines are being developed, evaluated and monitored it has become indispensable that academia and regulators develop a partnership that will foster a proactive process to support innovation and channel it into the continuous evolution of regulatory science.
Related information:
» Survey report - EMA consultation on the proposal of a collaboration framework with academia
Details
- Publication date
- 8 November 2016
- Author
- European Medicines Agency